NCT06459180 2026-04-17
TroFuse-020
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
4 trialsNCT04697628 2026-02-24
innovaTV 301
Seagen Inc.
Phase 3 Completed
NCT03386721 2023-02-21
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Phase 2 Terminated
NCT04943627 2022-10-05
Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)
Agenus Inc.
Phase 3 Withdrawn